Pages that link to "Q73296831"
Jump to navigation
Jump to search
The following pages link to Phillip Wong (Q73296831):
Displaying 14 items.
- Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer (Q29615679) (← links)
- Genetic basis for clinical response to CTLA-4 blockade in melanoma (Q29620863) (← links)
- Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes (Q34016867) (← links)
- CD8 T cell responses to infectious pathogens. (Q34987912) (← links)
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma (Q35748121) (← links)
- Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab (Q37709534) (← links)
- Feedback regulation of pathogen-specific T cell priming. (Q40653768) (← links)
- Cutting edge: antigen-independent CD8 T cell proliferation. (Q40807368) (← links)
- Rapid development of T cell memory. (Q50999062) (← links)
- Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion (Q75424728) (← links)
- A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma (Q90604662) (← links)
- Immunomodulatory Activity of a Colony-Stimulating Factor-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer: A Phase 1 Study (Q98733130) (← links)
- Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma (Q112278804) (← links)
- Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child (Q112304771) (← links)